Bibliography
- The Black Population: 2010. 2010 Census Briefs. 2011. Available from: http://www.census.gov/prod/cen2010/briefs/c2010br-06.pdf [Last accessed 28 February 2012]
- National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. 2011. Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf [Last accessed 6 September 2012]
- African Americans and Complications. Available from: http://www.diabetes.org/living-with-diabetes/complications/african-americans-and-complications.html [Last accessed 19 September 2011]
- Marshall MC Jr. Diabetes in African Americans. Postgrad Med J 2005;81(962):734-40
- Ten Facts about African Americans and Kidney Disease. Available from: http://www.kidney.org/news/newsroom/fs_new/10factsabtaframerkd.cfm [Last accessed 19 September 2011]
- Deacon CF. Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review. Diab Obes Metab 2011;13(1):7-18
- Del Prato S, Barnett AH, Huisman H, Effect of linagliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. Diab Obes Metab 2011;13(3):258-67
- Taskinen MR, Rosenstock J, Tamminen I, Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Diab Obes Metab 2011;13(1):65-74
- Gomis R, Espadero RM, Jones R, Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study. Diab Obes Metab 2011;13(7):653-61
- Owens DR, Swallow R, Dugi KA, Woerle HJ. Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study. Diabet Med 2011;28(11):1352-61
- Overview of Race and Hispanic Origin: 2010. 2010 Census Briefs. 2011. Available from: http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf [Last accessed 3 October 2011]
- Shavers-Hornaday VL, Lynch CF, Burmeister LF, Torner JC. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health 1997;2(1-2):31-45
- Powell JH, Fleming Y, Walker-Mcgill CL, Lenoir M. The project IMPACT experience to date: increasing minority participation and awareness of clinical trials. J Natl Med Assoc 2008;100(2):178-87
- Ard JD, Durant RW, Edwards LC, Svetkey LP. Perceptions of African-American culture and implications for clinical trial design. Ethn Dis 2005;15(2):292-9
- Kennedy BM, Kumanyika S, Ard JD, Overall and minority-focused recruitment strategies in the PREMIER multicenter trial of lifestyle interventions for blood pressure control. Contemp Clin Trials 2010;31(1):49-54
- Project IMPACT (Increase Minority Participation and Awareness of Clinical Trials). Available from: http://impact.nmanet.org [Last accessed 5 October 2011]